These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2904042)
1. Thalidomide for chronic graft-versus-host disease in children. Heney D; Lewis IJ; Bailey CC Lancet; 1988 Dec; 2(8623):1317. PubMed ID: 2904042 [No Abstract] [Full Text] [Related]
2. Thalidomide in the management of chronic graft-versus-host disease in children following bone marrow transplantation. Cole CH; Rogers PC; Pritchard S; Phillips G; Chan KW Bone Marrow Transplant; 1994 Dec; 14(6):937-42. PubMed ID: 7711671 [TBL] [Abstract][Full Text] [Related]
3. Thalidomide for graft-versus-host disease. McCarthy DM; Kanfer E; Taylor J; Barrett AJ Lancet; 1988 Nov; 2(8620):1135. PubMed ID: 2903342 [No Abstract] [Full Text] [Related]
5. Thalidomide back in good graces--seems to help GVHD patients. Oncology (Williston Park); 1988 Sep; 2(9):29. PubMed ID: 3275064 [No Abstract] [Full Text] [Related]
6. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children. Rovelli A; Arrigo C; Nesi F; Balduzzi A; Nicolini B; Locasciulli A; Vassallo E; Miniero R; Uderzo C Bone Marrow Transplant; 1998 Mar; 21(6):577-81. PubMed ID: 9543061 [TBL] [Abstract][Full Text] [Related]
7. Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease. Kulkarni S; Powles R; Sirohi B; Treleaven J; Saso R; Horton C; Atra A; Ortin M; Rudin C; Goyal S; Sankpal S; Meller S; Pinkerton CR; Mehta J; Singhal S Bone Marrow Transplant; 2003 Jul; 32(2):165-70. PubMed ID: 12838281 [TBL] [Abstract][Full Text] [Related]
8. Thalidomide in children undergoing bone marrow transplantation: series at a single institution and review of the literature. Mehta P; Kedar A; Graham-Pole J; Skoda-Smith S; Wingard JR Pediatrics; 1999 Apr; 103(4):e44. PubMed ID: 10103336 [TBL] [Abstract][Full Text] [Related]
9. Thalidomide use in pediatric patients. Bessmertny O; Pham T Ann Pharmacother; 2002 Mar; 36(3):521-5. PubMed ID: 11895068 [TBL] [Abstract][Full Text] [Related]
10. Thalidomide for severe acute graft-versus-host disease. Ringdén O; Aschan J; Westerberg L Lancet; 1988 Sep; 2(8610):568. PubMed ID: 2900947 [No Abstract] [Full Text] [Related]
11. The potential use of thalidomide in the therapy of graft-versus-host disease--a review of clinical and laboratory information. Wood PM; Proctor SJ Leuk Res; 1990; 14(5):395-9. PubMed ID: 2189044 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of thalidomide for treatment or prevention of chronic graft-versus-host disease. Flowers ME; Martin PJ Leuk Lymphoma; 2003 Jul; 44(7):1141-6. PubMed ID: 12916865 [TBL] [Abstract][Full Text] [Related]
14. [Sclerodermatous cutaneous reaction of graft vs host disease treated with thalidomide]. Pédailles S; Troussard X; Launay V; Bazin A; Sentias C; Surbled M Presse Med; 1993 Jan 2-16; 22(1):37. PubMed ID: 8469665 [No Abstract] [Full Text] [Related]
15. Thalidomide for the treatment of chronic graft-versus-host disease. Vogelsang GB; Farmer ER; Hess AD; Altamonte V; Beschorner WE; Jabs DA; Corio RL; Levin LS; Colvin OM; Wingard JR N Engl J Med; 1992 Apr; 326(16):1055-8. PubMed ID: 1549151 [TBL] [Abstract][Full Text] [Related]
16. Thalidomide for graft-versus-host disease after bone marrow transplantation. Saurat JH; Camenzind M; Helg C; Chapuis B Lancet; 1988 Feb; 1(8581):359. PubMed ID: 2893167 [No Abstract] [Full Text] [Related]
17. Graft-versus-host disease. Kaitin KI N Engl J Med; 1991 Aug; 325(5):357-8. PubMed ID: 2057040 [No Abstract] [Full Text] [Related]
18. Thalidomide--the need for a new clinical evaluation of an old drug. Ehninger G; Eger K; Stuhler A; Schuler U Bone Marrow Transplant; 1993; 12 Suppl 3():S26-8. PubMed ID: 8124253 [TBL] [Abstract][Full Text] [Related]